BackLigand Pharmaceuticals Overview
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

Ligand Pharmaceuticals Discounted Cash Flow

DCF Analysis for LGND.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$70.14

Current Fair Value

$70.14
72.3% Downside

Overvalued by 72.3% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading